Teva Pharmaceuticals Director of Business Development Salary
The average Teva Pharmaceuticals Director of Business Development earns an estimated $205,524 annually, which includes an estimated base salary of $159,286 with a $46,238 bonus. Teva Pharmaceuticals' Director of Business Development compensation is $39,221 more than the US average for a Director of Business Development. Director of Business Development salaries at Teva Pharmaceuticals can range from $120,000 - $290,000.
The Business Development Department at Teva Pharmaceuticals earns $2,818 more on average than the Engineering Department.
Last updated 9 months ago.
- $159,286
- avg. base
- $46,238
- avg. bonus
Director of Business Development Salaries at Teva Pharmaceuticals
Directors of Business Development earn $5,578 more than Directors of Business Development.
Compensation at Teva Pharmaceuticals by Department
The Business Development Department averages $2,818 more than the Engineering Department, and $10,180 less than the Product Department
Director of Business Development Compensation by Gender (All Companies)
The average female Director of Business Development at companies similar size to Teva Pharmaceuticals reported making $205,320, while the average male Director of Business Development at similar sized companies reported making $214,912.
Director of Business Development Compensation by Ethnicity (All Companies)
The average African American/Black Director of Business Development at companies similar size to Teva Pharmaceuticals reported making $217,667, while the average Hispanic or Latino Director of Business Development at similar sized companies reported making $185,667.
How Directors of Business Development at Teva Pharmaceuticals Rate Their Compensation
The majority of Directors of Business Development at Teva Pharmaceuticals believe they're not compensated fairly. 100% of Directors of Business Development at Teva Pharmaceuticals say they receive annual bonuses, and the majority (63%) are satisfied with their benefits. See more compensation ratings at Teva Pharmaceuticals
